RBC Capital Mkts slashes price target on Hookipa Pharma Inc [HOOK] – find out why.

GBS Stock

Hookipa Pharma Inc [NASDAQ: HOOK] closed the trading session at $1.51.

The stocks have a year to date performance of -24.88 percent and weekly performance of -3.21 percent. The stock has been moved at -45.88 percent over the last six months. The stock has performed 79.74 percent around the most recent 30 days and changed -14.20 percent over the most recent 3-months.

If compared to the average trading volume of 116.43K shares, HOOK reached to a volume of 225776 in the most recent trading day, which is why market watchdogs consider the stock to be active.

Here’s what leading stock market gurus have to say about Hookipa Pharma Inc [HOOK]:

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for HOOK shares is $2.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on HOOK stock is a recommendation set at 3.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

RBC Capital Mkts have made an estimate for Hookipa Pharma Inc shares, keeping their opinion on the stock as Sector Perform, with their previous recommendation back on December 20, 2024. While these analysts kept the previous recommendation, RBC Capital Mkts dropped their target price from $50 to $48. The new note on the price target was released on November 15, 2024, representing the official price target for Hookipa Pharma Inc stock. Previously, the target price had yet another raise to $0.50, while BofA Securities analysts kept a Underperform rating on HOOK stock.

The Average True Range (ATR) for Hookipa Pharma Inc is set at 0.18, with the Price to Sales ratio for HOOK stock in the period of the last 12 months amounting to 1.97. The Price to Book ratio for the last quarter was 0.53, with the Price to Cash per share for the same quarter was set at 3.31.

HOOK stock trade performance evaluation

Hookipa Pharma Inc [HOOK] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -3.21. With this latest performance, HOOK shares gained by 79.74% in over the last four-week period, additionally sinking by -45.88% over the last 6 months – not to mention a drop of -98.24% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for HOOK stock in for the last two-week period is set at 57.23, with the RSI for the last a single of trading hit 55.39, and the three-weeks RSI is set at 56.57 for Hookipa Pharma Inc [HOOK]. The present Moving Average for the last 50 days of trading for this stock 1.1284, while it was recorded at 1.5830 for the last single week of trading, and 2.6228 for the last 200 days.

Hookipa Pharma Inc [HOOK]: An insightful look at the core fundamentals

Hookipa Pharma Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 3.61 and a Current Ratio set at 3.61.

Earnings per share (EPS) analysis for Hookipa Pharma Inc [HOOK] stock

The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for HOOK. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Hookipa Pharma Inc go to 23.89%.

Hookipa Pharma Inc [HOOK]: Institutional Ownership

There are presently around $53.37%, or 53.44%% of HOOK stock, in the hands of institutional investors. The top three institutional holders of HOOK stocks are: ECOR1 CAPITAL, LLC with ownership of 5.72 million shares, which is approximately 4.5597%. ARTAL GROUP S.A., holding 5.67 million shares of the stock with an approximate value of $$3.35 million in HOOK stocks shares; and ARTAL GROUP S.A., currently with $$3.26 million in HOOK stock with ownership which is approximately 4.4003%.

The DBT News
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.